Erasca
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Erasca and other ETFs, options, and stocks.About ERAS
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
CEOJonathan E. Lim
CEOJonathan E. Lim
Employees103
Employees103
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees103
Employees103
ERAS Key Statistics
Market cap1.46B
Market cap1.46B
Price-Earnings ratio-11.47
Price-Earnings ratio-11.47
Dividend yield—
Dividend yield—
Average volume6.19M
Average volume6.19M
High today$6.49
High today$6.49
Low today$3.65
Low today$3.65
Open price$3.73
Open price$3.73
Volume41.38M
Volume41.38M
52 Week high$6.49
52 Week high$6.49
52 Week low$1.01
52 Week low$1.01
Stock Snapshot
Erasca(ERAS) stock is priced at $4.54, giving the company a market capitalization of 1.46B. It carries a P/E multiple of -11.47.
On 2026-01-08, Erasca(ERAS) stock traded between a low of $3.65 and a high of $6.49. Shares are currently priced at $4.54, which is +24.4% above the low and -30.0% below the high.
Erasca(ERAS) shares are trading with a volume of 41.38M, against a daily average of 6.19M.
In the last year, Erasca(ERAS) shares hit a 52-week high of $6.49 and a 52-week low of $1.01.
In the last year, Erasca(ERAS) shares hit a 52-week high of $6.49 and a 52-week low of $1.01.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
9.1%
Sell
9.1%
People also own
Based on the portfolios of people who own ERAS. This list is generated using Robinhood data, and it’s not a recommendation.